Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.4600
-0.0150 (-3.16%)
At close: Apr 17, 2025, 4:00 PM AEST

Cleo Diagnostics Statistics

Total Valuation

ASX:COV has a market cap or net worth of AUD 56.54 million. The enterprise value is 49.23 million.

Market Cap 56.54M
Enterprise Value 49.23M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date May 28, 2025
Ex-Dividend Date n/a

Share Statistics

ASX:COV has 128.50 million shares outstanding. The number of shares has increased by 25.28% in one year.

Current Share Class n/a
Shares Outstanding 128.50M
Shares Change (YoY) +25.28%
Shares Change (QoQ) +10.23%
Owned by Insiders (%) 32.04%
Owned by Institutions (%) n/a
Float 73.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 268.20
PB Ratio 7.60
P/TBV Ratio 8.01
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -15.89
EV / Sales 233.52
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -17.60

Financial Position

The company has a current ratio of 16.70

Current Ratio 16.70
Quick Ratio 16.51
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -34.46% and return on invested capital (ROIC) is -22.24%.

Return on Equity (ROE) -34.46%
Return on Assets (ROA) -21.46%
Return on Invested Capital (ROIC) -22.24%
Return on Capital Employed (ROCE) -42.98%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +148.65% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +148.65%
50-Day Moving Average 0.44
200-Day Moving Average 0.38
Relative Strength Index (RSI) 54.03
Average Volume (20 Days) 153,465

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:COV had revenue of AUD 210,812 and -3.10 million in losses. Loss per share was -0.03.

Revenue 210,812
Gross Profit 210,812
Operating Income -3.20M
Pretax Income -3.10M
Net Income -3.10M
EBITDA -3.14M
EBIT -3.20M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 7.31 million in cash and n/a in debt, giving a net cash position of 7.31 million or 0.06 per share.

Cash & Cash Equivalents 7.31M
Total Debt n/a
Net Cash 7.31M
Net Cash Per Share 0.06
Equity (Book Value) 7.44M
Book Value Per Share 0.06
Working Capital 7.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.79 million and capital expenditures -2,563, giving a free cash flow of -2.80 million.

Operating Cash Flow -2.79M
Capital Expenditures -2,563
Free Cash Flow -2.80M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -1,517.30%
Pretax Margin -1,469.73%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ASX:COV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -25.28%
Shareholder Yield -25.28%
Earnings Yield -5.48%
FCF Yield -4.95%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:COV has an Altman Z-Score of 50.4.

Altman Z-Score 50.4
Piotroski F-Score n/a